These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31016803)

  • 21. Patient-Oriented Eczema Measure score: A Useful Tool for Web-Based Surveys in Patients with Atopic Dermatitis.
    Kido-Nakahara M; Nakahara T; Yasukochi Y; Ulzii D; Furue M
    Acta Derm Venereol; 2020 May; 100(10):adv00159. PubMed ID: 32449786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (QUEST-AD): Baseline treatment patterns and unmet needs assessment.
    Wei W; Ghorayeb E; Andria M; Walker V; Schnitzer J; Kennedy M; Chen Z; Belland A; White J; Silverberg JI
    Ann Allergy Asthma Immunol; 2019 Oct; 123(4):381-388.e2. PubMed ID: 31325566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with Methotrexate in Infants and Toddlers with Atopic Dermatitis: A Retrospective Multi-Center Study.
    Barak Levitt JA; Alemi S; Ollech A; Reiss-Huss S; Sah M; Renert-Yuval Y; Friedland R; Greenberger S; Cohen Barak E
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe and ChRonic Atopic dermatitis Treatment CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment Registry.
    Larsen HH; Vittrup I; Ruge IF; Elberling J; Skov L; Ibler K; Jemec GB; Mørtz CG; Bach RO; Bindslev-Jensen C; Dalager M; Agner T; Deleuran M; Vestergaard C; Thyssen JP
    Acta Derm Venereol; 2022 Aug; 102():adv00760. PubMed ID: 35670330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Atopic Dermatitis Severity With Learning Disability in Children.
    Wan J; Mitra N; Hooper SR; Hoffstad OJ; Margolis DJ
    JAMA Dermatol; 2021 Apr; 157(6):1-7. PubMed ID: 33851961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical corticosteroid phobia among caretakers of children with atopic dermatitis: A cross-sectional study using TOPICOP in Japan.
    Saito-Abe M; Futamura M; Yamamoto-Hanada K; Yang L; Suzuki K; Ohya Y
    Pediatr Dermatol; 2019 May; 36(3):311-316. PubMed ID: 30882946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt.
    El-Khalawany MA; Hassan H; Shaaban D; Ghonaim N; Eassa B
    Eur J Pediatr; 2013 Mar; 172(3):351-6. PubMed ID: 23229188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different potencies of topical corticosteroids for a better treatment strategy in children with atopic dermatitis (the Rotterdam Eczema study): protocol for an observational cohort study with an embedded randomised open-label controlled trial.
    van Halewijn KF; Bohnen AM; van den Berg PJ; Pasmans SGMA; Bindels PJE; Elshout G
    BMJ Open; 2019 Jun; 9(6):e027239. PubMed ID: 31221882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate for refractory adult atopic dermatitis leads to alterations in cutaneous IL-31 and IL-31RA expression.
    Samorano LP; Manfrere KCG; Pereira NV; Takaoka R; Valente NYS; Sotto MN; Silva LFF; Sato MN; Aoki V
    An Bras Dermatol; 2024; 99(1):72-79. PubMed ID: 37730501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study.
    Poole CD; Chambers C; Sidhu MK; Currie CJ
    Br J Dermatol; 2009 Dec; 161(6):1335-40. PubMed ID: 19754867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
    Hon KL; Ching GK; Leung TF; Chow CM; Lee KK; Ng PC
    J Dermatolog Treat; 2009; 20(3):141-5. PubMed ID: 18951236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
    Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
    Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
    Totri CR; Eichenfield LF; Logan K; Proudfoot L; Schmitt J; Lara-Corrales I; Sugarman J; Tom W; Siegfried E; Cordoro K; Paller AS; Flohr C
    J Am Acad Dermatol; 2017 Feb; 76(2):281-285. PubMed ID: 27855965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
    Cork MJ; Eckert L; Simpson EL; Armstrong A; Barbarot S; Puig L; Girolomoni G; de Bruin-Weller M; Wollenberg A; Kataoka Y; Remitz A; Beissert S; Mastey V; Ardeleanu M; Chen Z; Gadkari A; Chao J
    J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791
    [No Abstract]   [Full Text] [Related]  

  • 36. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
    Schmitt J; Abraham S; Trautmann F; Stephan V; Fölster-Holst R; Homey B; Bieber T; Novak N; Sticherling M; Augustin M; Kleinheinz A; Elsner P; Weidinger S; Werfel T
    J Dtsch Dermatol Ges; 2017 Jan; 15(1):49-59. PubMed ID: 27862987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment patterns in UK adult patients with atopic dermatitis treated with systemic immunosuppressants: data from The Health Improvement Network (THIN).
    Eckert L; Amand C; Gadkari A; Rout R; Hudson R; Ardern-Jones M
    J Dermatolog Treat; 2020 Dec; 31(8):815-820. PubMed ID: 31305182
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and tolerability of a cream containing AR-GG27® (sorbityl furfural palmitate) in the treatment of mild/moderate childhood atopic dermatitis associated with pityriasis alba. A double-blind, placebo-controlled clinical trial.
    Patrizi A; Raone B; Raboni R; Neri I
    G Ital Dermatol Venereol; 2012 Dec; 147(6 Suppl 1):1-8. PubMed ID: 23007324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
    Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
    Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.